Physician Payments from Pharmaceutical Companies Related to Cancer Drugs.

Although industry-sponsored education may also serve marketing purposes, the absence of association between industry payments and Medicare spending and the decline in payments subsequent to approval are consistent with claims that industry payments function to facilitate physician education.